Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Life Science Alliance
|
January 18, 2022
Malaria abrogates O'nyong-nyong virus pathologies by restricting virus infection in nonimmune cells
Anthony Torres-Ruesta, Teck-Hui Teo, Yi-Hao Chan, et al.
Frontiers in Immunology
|
June 2, 2020
Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection
Yi-Hao Chan, Teck-Hui Teo, Anthony Torres-Ruesta, et al.
Journal of Medical Virology
|
May 22, 2023
Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection
Siew-Wai Fong, Yun Shan Goh, Anthony Torres-Ruesta, et al.
Nature Communications
|
October 20, 2025
Mosquito salivary sialokinin reduces monocyte activation and chikungunya virus-induced inflammation via neurokinin receptors
Siew-Wai Fong, Jeslin J L Tan, Vaishnavi Sridhar, et al.
Ebiomedicine
|
July 26, 2020
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
Siti Naqiah Amrun, Cheryl Yi-Pin Lee, Bernett Lee, et al.
Nature Communications
|
June 3, 2020
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
Chek Meng Poh, Guillaume Carissimo, Bei Wang, et al.
Clinical & Translational Immunology
|
February 25, 2021
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant
Cheryl Yi-Pin Lee, Siti Naqiah Amrun, Rhonda Sin-Ling Chee, et al.
Journal of Clinical Immunology
|
October 30, 2021
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection
Siew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, et al.
EMBO Molecular Medicine
|
May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
Vaccine
|
September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial
Xuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Life Science Alliance
|
January 18, 2022
Malaria abrogates O'nyong-nyong virus pathologies by restricting virus infection in nonimmune cells
Anthony Torres-Ruesta, Teck-Hui Teo, Yi-Hao Chan, et al.
Frontiers in Immunology
|
June 2, 2020
Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection
Yi-Hao Chan, Teck-Hui Teo, Anthony Torres-Ruesta, et al.
Journal of Medical Virology
|
May 22, 2023
Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection
Siew-Wai Fong, Yun Shan Goh, Anthony Torres-Ruesta, et al.
Nature Communications
|
October 20, 2025
Mosquito salivary sialokinin reduces monocyte activation and chikungunya virus-induced inflammation via neurokinin receptors
Siew-Wai Fong, Jeslin J L Tan, Vaishnavi Sridhar, et al.
Ebiomedicine
|
July 26, 2020
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
Siti Naqiah Amrun, Cheryl Yi-Pin Lee, Bernett Lee, et al.
Nature Communications
|
June 3, 2020
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
Chek Meng Poh, Guillaume Carissimo, Bei Wang, et al.
Clinical & Translational Immunology
|
February 25, 2021
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant
Cheryl Yi-Pin Lee, Siti Naqiah Amrun, Rhonda Sin-Ling Chee, et al.
Journal of Clinical Immunology
|
October 30, 2021
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection
Siew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, et al.
EMBO Molecular Medicine
|
May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
Vaccine
|
September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial
Xuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Page
of 5